Article
TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype.
Leukemia research - 1 Jan 2009
Zainuddin Norafiza, Berglund Mattias, Wanders Alkwin, Ren Zhi-Ping, Amini Rose-Marie, Lindell Monica, Kanduri Meena, Roos Göran, Rosenquist Richard, Enblad Gunilla
Abstract excerpt
Presence of TP53 mutations has been associated with poor prognosis in diffuse large B-cell lymphoma (DLBCL), although this has remained controversial. The TP53 codon 72 polymorphism has shown negative impact on cancer survival, but this has not been analyzed in DLBCL. Furthermore, the MDM2 SNP309...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
